v3 Template
P

ProtaGene

Biotechnology and Pharmaceuticals ~300 employees
Founded
--
Employees (Est.)
~300
15 leaders known
Total Funding
$40.0M
Funding Rounds
1
Last Funding
2023-11-20

About ProtaGene

ProtaGene is a company focused on providing advanced, integrated, and complete analytical solutions for biopharmaceutical, cell, and gene therapy developers. Their mission is to support global clients' decision-making throughout the development process, from research to commercial product release, with a commitment to analytical excellence and quality.

Products & Services

Biologic Drug Analytics:Advanced analytics and complete data packages for all stages of biotherapeutic development, including product characterization, process development, manufacturing, QC, biosimilar support, clinical sample mapping, and cell-based assays.
Cell & Gene Therapeutic Analytics:Industry-leading solutions for vector analytics, molecular bioanalysis, integration site analysis, bioinformatics, genome and gene editing, gene expression quantitation, and commercial patient testing to advance gene therapy safety.
Commercial Patient Testing:Testing services for commercial patients as part of cell and gene therapy programs.
Analytical Systems:State-of-the-art technology and extensive analytical capabilities to support biotherapeutic and gene & cell therapy projects.

Specialties

Biologic Drug Analytics Cell and Gene Therapy Analytics Vector Analytics Molecular Bioanalysis Integration Site Analysis Bioinformatics and NGS Data Analytics Genome and Gene Editing Cell-based Assays Product Characterization Biosimilar Program Support

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Capital
T: -
FT: Venture Capital
A: 40000000
MR: -
FA: nearly $40 million
FAN: 40000000
D: 2023-11-20
FD: 2023-11-20
1 investors
Venture Capital Latest
2023-11-20
$40.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michael Stump

President, US

R

Roland Moussa, PhD

President, EU

M

Michael Fudge

Chief Operating Officer

T

Tina Gerhards

Vice President, Quality Management

A

André Abts

Vice President, Project Management CMC

J

Julian Stendler

Vice President, IT

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

ProtaGene Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology and Pharmaceuticals
Company Size
~300 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro